Launch prices for self-administered targeted anticancer therapies have grown precipitously,” researchers wrote.

Apotex has launched the first generic version of Tasigna (nilotinib), a TKI used to treat adult and pediatric patients with Ph+ CML.

Dozens of staff at the NIH walked out of a recent town hall meeting after Director Dr Jay Bhattacharya suggested the agency may have helped fund research that caused the COVID-19 pandemic.

The median time to treatment initiation across all cancer types increased from 21 days in 2004 to 28 days in 2015. The median time to treatment initiation is increasing across cancer types, and this ...

We need to rethink our approach in responding to cancers in our younger women patients,” said Hope S. Rugo, MD.

Cancer organizations are urging researchers, oncologists, and other stakeholders to advocate for cancer research.

These findings support the need for a phase III randomized controlled trial to definitively determine whether the addition of an antiangiogenic to a second or even a third-generation TKI provides ...

(HealthDay News) — China has promised to give $500 million to the World Health Organization (WHO) over the next 5 years, positioning itself to become the group’s top donor, The Washington Post ...

Health care data breaches that compromised protected health information more than doubled from 2010 to 2024 in the US, data suggest.

The results of our study suggest a concerning pattern in cancer center advertising, particularly among top-ranked institutions,” researchers wrote.

Our large observational study adds long-term survival to the mounting data supporting the use and safety of conservative surgery for low-risk, early-stage cervical carcinoma,” the researchers wrote.

We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.